![Frank Neumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Frank Neumann formerly worked at bluebird bio, Inc., as Vice President & Head-Oncology Clinical Research, Verastem, Inc., as Chief Medical Officer in 2021, and Kite Pharma, Inc., as Head-Clinical Development from 2021 to 2024.
Dr. Neumann received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
Eerdere bekende functies van Frank Neumann
| Bedrijven | Functie | Einde |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01-05-2024 |
| VERASTEM, INC. | Hoofd Techniek/Wetenschap/O&O | 20-01-2021 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Frank Neumann
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heinrich-Heine-Universität Düsseldorf
 Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
